We are live on ! Find out more
LMAT icon

LeMaitre Vascular

185 hedge funds and large institutions have $1.08B invested in LeMaitre Vascular in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 67 increasing their positions, 58 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

594% more call options, than puts

Call options by funds: $1.86M | Put options by funds: $268K

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

23% more capital invested

Capital invested by funds: $875M → $1.08B (+$204M)

16% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 58

3% more funds holding

Funds holding: 179185 (+6)

1.44% less ownership

Funds ownership: 87.37%85.93% (-1.4%)

Holders
185
Holders Change
+6
Holders Change %
+3.35%
% of All Funds
3.22%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
28
Increased
67
Reduced
58
Closed
21
Calls
$1.86M
Puts
$268K
Net Calls
+$1.59M
Net Calls Change
+$217K

LMAT Hedge Fund Activity: Q2 2021 in Review

185 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2021, worth a combined $1.08B — up 23% from $875M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new LMAT positions and 21 closed out — a net gain of 7 holders — while 67 added to existing stakes and 58 trimmed.

The largest buyer was ProShare Advisors, adding an estimated $9.63M. The largest seller was Summit Creek Advisors, cutting an estimated $9.13M.

  • 185 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2021, up from 179 in Q1 2021.
  • Funds reported $1.08B of LeMaitre Vascular stock for Q2 2021, up 23% quarter-over-quarter.
  • 28 funds opened new LeMaitre Vascular positions in Q2 2021 and 21 closed out, a net change of +7 holders.
  • The largest LeMaitre Vascular buyer in Q2 2021 was ProShare Advisors, an estimated $9.63M added.
  • The largest LeMaitre Vascular seller in Q2 2021 was Summit Creek Advisors, an estimated $9.13M sold.

Based on aggregated 13F filings for Q2 2021.